PDCD1 and neoplasm: The PD-1 pathway restrains the interactions between tumor-infiltrating PD-1+ T cells and other immune cells or tumor cells expressing PD-1 ligands in the TME as well as tumor antigen presentation by APCs to tumor-specific T cells during priming in the tumor-draining lymph nodes (TDLNs) (Figure 1).